期刊文献+

人跨膜蛋白39A原核表达载体构建、条件优化及可溶性表达 被引量:2

Construction of prokaryotic expression vector, optimization of expression conditions and soluble expression of human TMEM39A
下载PDF
导出
摘要 目的构建人跨膜蛋白39A基因(TMEM39A)的原核表达载体,优化表达条件并获得可溶性表达的TMEM39A。方法以HEK293细胞的总RNA为模板,反转录PCR扩增TMEM39A,构建其原核表达载体pGEX-6P-1-TMEM39A,并在不同温度、IPTG浓度、A600nm值及时间条件进行诱导表达,然后利用上述获得的最佳诱导条件进行大量表达,分析其可溶性和抗原性。结果重组表达载体pGEX-6P-1-TMEM39A与GenBank中的TMEM39A(登录号:BC021277.2)的核苷酸序列同源性为99.9%,氨基酸序列同源性为100%。重组蛋白GST-TMEM39A在69和60 ku处出现两条特异性条带,采用单因素方法对不同温度、IPTG浓度、A600nm值及时间进行分析得出GST-TMEM39A的最佳诱导条件为25℃、A600nm值为0.6~0.8、IPTG浓度为0.1 mmol/L诱导9 h;在此基础上进行大量表达,并以可溶性形式获得了TMEM39A与GST蛋白的融合表达。结论成功构建了TMEM39A的原核表达载体,确定了GST-TMEM39A的最佳表达条件并实现其的可溶性表达,为后续纯化TMEM39A、制备抗体开展功能研究奠定物质基础,并为深入探讨TMEM39A与许多疾病或病毒的关系提供科学依据。 Objective To construct prokaryotic expression vector of human TMEM39A,optimize expression conditions and obtain soluble TMEM39 A.Methods TMEM39A was amplified from HEK293 cells by RT-PCR to construct its prokaryotic expression vector pGEX-6 P-1-TMEM39A,and the induced expression was conducted at different temperatures,IPTG concentrations,A600 nm values and time conditions.Finally,expression of the recombinant protein GST-TMEM39 A was carried out to analyze its solubility and antigenicity by using the best induction conditions.Results The nucleotide sequence homology of the recombinant expression vector pGEX-6 P-1-TMEM39A and TMEM39 A in GenBank(BC021277.2)was 99.9%and the amino acid sequence homology was 100%.The recom-binant protein GST-TMEM39 A showed two specific bands at 69 ku and 60 ku by Western blot analysis.The optimal induction conditions for GST-TMEM39 A was 25℃,A600 nm value of 0.6-0.8,0.1 mmol/L IPTG induced 9 h.On this basis,the fusion expression of TMEM39 A and GST protein was obtained in a soluble form.Conclusions The prokaryotic expression vector of TMEM39 A is successfully constructed,the optimal expression condition of GST-TMEM39 A is determined and its soluble expression is realized,which lays a physical foundation for the subsequent purification of TMEM39 A and the preparation of antibodies for functional studies,and provides scientific basis for further study about the relationship between TMEM39 A and many diseases or viruses.
作者 李向茸 马瑞仙 李倩 王兴陇 李生军 张海霞 冯若飞 LI Xiang-rong;MA Rui-xian;LI Qian;WANG Xing-long;LI Sheng-jun;ZHANG Hai-xia;FENG Ruo-fei(Biomedical Research Center,the Key Boiengineering and Technology Laboratory of Nationality Commission,Northwest Minzu University,Lanzhou 730030,China;Biomedical Research Center,Gansu Tech Innovation Center of Animal Cell,Northwest Minzu University,Lanzhou 730030,China;Life Science and Engineering College,Northwest Minzu University,Lanzhou 730030,China)
出处 《基础医学与临床》 CSCD 2019年第7期932-936,共5页 Basic and Clinical Medicine
基金 国家自然科学基金(31460665) 教育部“创新团队发展计划”(IRT_17R88) 西北民族大学“双一流”引导专项生物工程特色学科(10018703,1001070204)
关键词 跨膜蛋白39A 条件优化 融合蛋白 可溶性表达 TMEM39A optimization of expression conditions fusion protein soluble expression
  • 相关文献

参考文献2

二级参考文献32

  • 1Lau CS, Yin G, Mok MY. Ethnic and geographical differences in systemic lupus erythematosus: an overview EJ]. Lupus, 2006, 15 (ll): 715-9.
  • 2Zeng QY, Chen R, Darmawan J, et al. Rheumatic diseases in China IJ]. Arthritis Res Ther, 2008, 10(1): 1-11.
  • 3Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden[J]. Lupus, 2006, 15(5): 308-18.
  • 4Tsokos GC. Systemic lupus erythematosus[J]. N Engl J Med, 2011, 365(22): 2110-21.
  • 5Han JW, Zheng HF, Cui Y, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus[J]. Nat Genet, 2009, 41(11): 1234-7.
  • 6Lessard C J, Adrianto I, Ice JA, et al. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a Large-Scale multiracial replication study IJ]. Am J Hum Genet, 2012, 90(4): 648-60.
  • 7International Multiple Sclerosis Genetics Consortium (IMSGC).Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci[J]. Hum Mol Genet, 2010, 19: 953-62.
  • 8Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1997, 40(9): 1725.
  • 9Hahn BH, Mcmahon MA, Wilkinson A, et al. American college of rheumatology guidelines for screening, treatment, and management of lupus nephritis [J]. Arthritis Care Res (Hoboken), 2012, 64(6): 797-808.
  • 10Kotzin BL. Systemic lupus erythematosus [J]. Cell, 1996, 3(85): 303-6.

共引文献3

同被引文献15

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部